Literature DB >> 8668849

Influenza virus pneumonia: pathogenesis, treatment, and prevention.

P A Piedra1.   

Abstract

The aim of this review is to describe the detrimental impact influenza virus has on an individual as well as on the community and to reinforce the strategies of prevention and treatment of this disease. The influenza viruses are capable of causing annual epidemics because of the constant changes that occur at the antigenic sites of the surface proteins. These antigenic changes, also known as antigenic drift (minor change) and antigenic shift (major change), allow the influenza virus to infect a substantial segment of the population with incomplete or no immunity. Composition of the influenza virus vaccine is changed on a yearly basis to provide the best match to new influenza virus strain(s) predicted to cause the next epidemic. Only by annual administration of influenza virus vaccine prior to the epidemic can health care providers expect to prevent influenza virus pneumonia and its associated complications in high-risk groups. Recent studies have demonstrated the medical prudence and cost effectiveness of preventing influenza virus infections in high-risk groups who are most susceptible to the complications of the influenza virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8668849

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  5 in total

1.  Comparison of the Denka-Seiken INFLU A.B-Quick and BD Directigen Flu A+B kits with direct fluorescent-antibody staining and shell vial culture methods for rapid detection of influenza viruses.

Authors:  James J Dunn; Chris Gordon; Christy Kelley; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Immunodominant peptides from conserved influenza proteins--a tool for more efficient vaccination in the elderly?

Authors:  Giovanni Almanzar; Dietmar Herndler-Brandstetter; Sandra Vega Chaparro; Brigitte Jenewein; Michael Keller; Beatrix Grubeck-Loebenstein
Journal:  Wien Med Wochenschr       Date:  2007

Review 3.  Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

Authors:  G He; J Massarella; P Ward
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 4.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

Review 5.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.